A heart health company in Princeton is seeking a Director of CMC Drug Substance Development to lead the development of both early-stage and late-stage drug candidates. This position is critical for overseeing the end-to-end API development processes, ensuring quality and compliance with regulatory expectations. The ideal candidate will have over 10 years of relevant experience, including expertise in small molecule and oligonucleotide product development, strong leadership skills, and a solid understanding of GMP regulations. Competitive compensation is offered, with a salary range of $202,000 - $263,000 USD.
#J-18808-Ljbffr
#J-18808-Ljbffr